Health Canada is implementing ICH Q12 in a phased manner, with an initial, targeted change for stakeholders: within BRDD, industry will be able to submit Post Approval Change Management Protocols (PACMPs) as a new, more predictable mechanism to manage post-approval changes, beginning August 13, 2026, supported by updated guidance. This first phase does not include broader Q12 elements such as Established Conditions (ECs), and does not yet apply to PDD-regulated products; additional expansions will follow. Overall, this represents a shift toward more structured, lifecycle-based regulatory oversight aligned with international standards, while maintaining a controlled and gradual implementation approach.




